Skip to main content

Advertisement

SpringerLink
Log in

Hyperthyroidism and thyroid autoimmunity induced by sorafenib in metastatic renal cell cancer

  • Letter to the Editor
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. M. Grossmann, E. Premaratne, J. Desai, I.D. Davis, Thyrotoxicosis during sunitinib treatment for renal cell carcinoma. Clin Endocrinol (Oxf) 69(4), 669–672 (2008)

    Article  CAS  Google Scholar 

  2. H. Miyake, T. Kurahashi, K. Yamanaka, Y. Kondo, M. Muramaki, A. Takenaka, T.A. Inoue, M. Fujisawa, Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: a prospective evaluation. Urol Oncol 28(5), 515–519 (2010)

    Article  PubMed  CAS  Google Scholar 

  3. I. Tamaskar, R. Bukowski, P. Elson, A.G. Ioachimescu, L. Wood, R. Dreicer, T. Mekhail, J. Garcia, B.I. Rini, Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib. Ann. Oncol. 19(2), 265–268 (2008)

    Article  PubMed  CAS  Google Scholar 

  4. J.H. Finke, B. Rini, J. Ireland, P. Rayman, A. Richmond, A. Golshayan, L. Wood, P. Elson, J. Garcia, R. Dreicer, R. Bukowski, Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients. Clin Cancer Res. Off J. Am. Assoc. Cancer Res. 14(20), 6674–6682 (2008)

    Article  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Faculty of Medicine, Gazi University, Gazi Üniversitesi Hastanesi, Endokrinoloji ve Metabolizma BD, 06100, Beşevler, Ankara, Turkey

    Ceyla Konca Degertekin, Füsun Baloş Törüner & Müjde Aktürk

  2. Department of Medical Oncology, Faculty of Medicine, Gazi University, Gazi Üniversitesi Hastanesi, Onkoloji BD, 06100, Beşevler, Ankara, Turkey

    Uğur Coşkun & Umut Demirci

Authors
  1. Ceyla Konca Degertekin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Uğur Coşkun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Füsun Baloş Törüner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Müjde Aktürk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Umut Demirci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ceyla Konca Degertekin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konca Degertekin, C., Coşkun, U., Baloş Törüner, F. et al. Hyperthyroidism and thyroid autoimmunity induced by sorafenib in metastatic renal cell cancer. Endocrine 42, 756–757 (2012). https://doi.org/10.1007/s12020-012-9683-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-012-9683-2

Keywords

Search

Navigation